Literature DB >> 5133607

Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent.

G E Housholder, T L Loo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5133607

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  4 in total

Review 1.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Pharmacokinetics and metabolism of beta-2'-deoxythioguanosine and 6-thioguanine in man.

Authors:  K Lu; J A Benvenuto; G P Bodey; J A Gottlieb; M G Rosenblum; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.

Authors:  H Breithaupt; A Dammann; K Aigner
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Disposition and metabolism of thiopurines III. beta-2'-Deoxythioguanosine and 6-thioguanine in the dog.

Authors:  T L Loo; K Lu; J A Benvenuto; M G Rosenblum
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.